ArticleDrug design, development and therapy2026
Effects of Ozone Therapy on the Bladder of Rats with Streptozocin-Induced Diabetes.
Article in Drug design, development and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Diabetes mellitus (DM), an increasingly prevalent condition worldwide, leads to complications in many organs. Diabetic cystopathy is one of the most frequent urological complications impairing the quality of life. Ozone is used therapeutically in various conditions due to its regulatory effects on oxidant status, as well as its microbicidal and immune-modulatory properties. We aimed to determine the effects of ozone on diabetic bladders, focusing on morphological alterations, inflammatory changes, and serum oxidant status. Methods: Twenty-four male Wistar Albino rats were randomly assigned to four groups (n=6 each): control (C), ozone (O), DM, and ozone-administered DM (DM+O). Four weeks after diabetes induction by intraperitoneal streptozotocin injection, O and DM+O rats received daily rectal ozone insufflation for 7 days. At the end of the fifth week, serum samples were collected to evaluate oxidant status, while bladders were analyzed by light and electron microscopy and investigated immunohistochemically for inflammatory cytokines. Results: Compared with the DM group, the DM+O group showed lower serum glucose and TOS levels and higher TAS levels, along with lower OSI values. Histologically, the DM+O group had a higher connective tissue-to-bladder wall ratio, a lower muscle tissue-to-bladder wall ratio, and a lower muscle-to-connective tissue ratio than the DM group. TNF-α and TGF-β immunostaining intensities were lower in the DM+O group compared to the DM group. IL-10 immunostaining intensity was higher in the DM+O group than in the DM group. The thickness of the urothelial basement membrane in the DM+O group was greater than in the DM group. Conclusion: Study findings suggest ozone may limit oxidative stress, inflammation, and structural alterations in the diabetic bladder, indicating a potential supportive role alongside standard diabetes treatment; further studies are needed to confirm its clinical relevance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.